The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
APA InstituteFull Access

IPS Forum Will Help Psychiatrists Explain Medicare Part D

Published Online:https://doi.org/10.1176/pn.40.16.00400021a

Aforum that will provide APA members with the practical information they need to help their patients navigate Medicare's new Part D pharmaceutical benefit has been added to the schedule of APA's 2005 Institute on Psychiatric Services.

The institute will be held in San Diego from October 5 to 9 (see box on Original article: page 27 for registration information).

The forum, “Readying for the New Medicare Pharmacy Benefit: The Part D Challenge,” will be sponsored by APA's Office of Healthcare Systems and Financing and chaired by Director Irvin “Sam” Muszynski. It is part of APA's ongoing effort to educate members about Medicare's new prescription drug benefit, which begins on January 1, 2006.

The forum will be held on Thursday, October 6, from 10 a.m. to 11:30 a.m.

Said Muszynski, “Deciding which Part D pharmacy plan to participate in will be a daunting task for almost all Medicare beneficiaries, but especially for dual-eligible beneficiaries, whose drug benefit will be transferred from their state's Medicaid program to Medicare. We anticipate that patients will be very dependent on their physicians to help them make the right decision.” ▪